SCHEMBL4302156

SCHEMBL4302156

S=C1C[CH]CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL89324 0.53
SCHEMBL20719507 0.50
SCHEMBL940079 0.48
SCHEMBL12172386 0.45
SCHEMBL12172388 0.45
Ethylene Thiourea SCHEMBL41176 0.45
SCHEMBL5241396 0.40
Hydrochloric Acid SCHEMBL9573677 0.35
Hydrochloric Acid SCHEMBL9104923 0.35
Hydrochloric Acid SCHEMBL72335 0.35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0597423-B1 Azetidinone compound and process for preparation thereof TANABE SEIYAKU CO (JP) 2002-03-06 EP claimed
EP-0582291-B1 Process for preparing carbapenem derivatives TANABE SEIYAKU CO (JP) 1997-11-05 EP claimed
US-5359059-A Cyclization of azetidinone compound with base and silylating agent TANABE SEIYAKU CO., LTD. (JP) 1994-10-25 US claimed
EP-0597423-A2 Azetidinone compound and process for preparation thereof TANABE SEIYAKU CO., LTD. (JP) 1994-05-18 EP claimed
EP-0582291-A1 Process for preparing carbapenem derivatives TANABE SEIYAKU CO., LTD. (JP) 1994-02-09 EP claimed
US-8507546-B2 Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases INSTITUTO DE MEDICINA MOLECULAR, FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA (PT) 2013-08-13 US disclosed
US-20120276121-A1 USE OF INHIBITORS OF SCAVENGER RECEPTOR CLASS PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES INSTITUTO DE MEDICINA MOLECULAR, FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA (PT) 2012-11-01 US disclosed
US-20090324580-A1 Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases CENIX BIOSCIENCE GMBH (DE) 2009-12-31 US disclosed
EP-1991215-A1 USE OF INHIBITORS OF SCAVENGER RECEPTOR CLASS PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES Cenix Bioscience GmbH (DE) 2008-11-19 EP disclosed
WO-2007101710-A1 USE OF INHIBITORS OF SCAVENGER RECEPTOR CLASS PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES CENIX BIOSCIENCE GMBH (DE) 2007-09-13 WO disclosed
EP-0913151-B1 ANTI-HELICOBACTER PYLORI COMPOSITIONS CONTAINING 1-METHYLCARBAPENEM DERIVATIVES AS THE ACTIVE INGREDIENT SANKYO CO (JP) 2002-09-04 EP disclosed
US-6180621-B1 ADMINISTERING TO WARM-BLOODED ANIMALS FOR TREATMENT AND PREVENTION OF INFECTIOUS DISEASES CAUSED BY HELICOBACTER PYLORI SANKYO COMPANY, LIMITED (JP) 2001-01-30 US disclosed
EP-0913151-A1 ANTI-HELICOBACTER PYLORI COMPOSITIONS CONTAINING 1-METHYLCARBAPENEM DERIVATIVES AS THE ACTIVE INGREDIENT Sankyo Company, Limited (JP) 1999-05-06 EP disclosed
EP-0474243-B1 1-Methylcarbapenem derivatives and process for preparation thereof TANABE SEIYAKU CO (JP) 1998-04-01 EP disclosed
US-5208348-A Intermediates for thienamycin derivatives TANABE SEIYAKU CO., LTD. (JP) 1993-05-04 US disclosed
US-5153187-A Microbiocides having stability against dehydropeptidase and high absorrbability by oral administration TANABE SEIYAKU CO., LTD. (JP) 1992-10-06 US disclosed
EP-0474243-A1 1-Methylcarbapenem derivatives and process for preparation thereof TANABE SEIYAKU CO., LTD. (JP) 1992-03-11 EP disclosed